Mitral Regurgitation - Valvular Heart Disease Guidelines

Mitral Regurgitation Guidelines App

ACC/AHA Valvular Heart Disease - Mitral Regurgitation GUIDELINES Apps brought to you charge courtesy of Guideline Central and Abbott Vascular.

Issue link: https://eguideline.guidelinecentral.com/i/674356

Contents of this Issue

Navigation

Page 8 of 15

Valve Hemodynamics a Associated Cardiac Findings Symptoms • No MR jet or small central jet area <20% LA on Doppler • Small vena contracta <0.30 cm • Normal or mildly dilated LV with fixed (infarction) or inducible (ischemia) regional wall motion abnormalities • Primary myocardial disease with LV dilation and systolic dysfunction Symptoms due to coronary ischemia or HF may be present that respond to revascularization and appropriate medical therapy • ERO <0.20 cm 2 b • RVol <30 mL • RF <50% • Regional wall motion abnormalities with reduced LV systolic function • LV dilation and systolic dysfunction due to primary myocardial disease Symptoms due to coronary ischemia or HF may be present that respond to revascularization and appropriate medical therapy • ERO ≥0.20 cm 2 b • RVol ≥30 mL • RF ≥50% • Regional wall motion abnormalities with reduced LV systolic function • LV dilation and systolic dysfunction due to primary myocardial disease Symptoms due to coronary ischemia or HF may be present that respond to revascularization and appropriate medical therapy • ERO ≥0.20 cm 2 b • RVol ≥30 mL • RF ≥50% • Regional wall motion abnormalities with reduced LV systolic function • LV dilation and systolic dysfunction due to primary myocardial disease • HF symptoms due to MR persist even after revascularization and optimization of medical therapy • Decreased exercise tolerance • Exertional dyspnea a Several valve hemodynamic criteria are provided for assessment of MR severity, but not all criteria for each category will be present in each patient. Categorization of MR severity as mild, moderate, or severe depends on data quality and integration of these parameters in conjunction with other clinical evidence. b e measurement of the proximal isovelocity surface area by 2D TTE in patients with chronic secondary MR underestimates the true ERO due to the crescent shape of the proximal convergence. 7

Articles in this issue

view archives of Mitral Regurgitation - Valvular Heart Disease Guidelines - Mitral Regurgitation Guidelines App